Biomimetic Dendritic Cell-Based Nanovaccines for Reprogramming the Immune Microenvironment to Boost Tumor ImmunotherapyWeizhong Wang, Jintao Gu, Yuxin Wu et al.|ACS Nano|2024Cited by 26
Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticlesCheng Zou, Meng Li, Xiao Liu et al.|Journal of Nanobiotechnology|2025Cited by 15
Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cellsMaorong Zhu, Zhengcong Cao, Yuxin Wu et al.|Journal of Nanobiotechnology|2026Cited by 0